March 27th 2024
A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Data still hazy for immediate postpartum hormonal contraception and postpartum depression
May 6th 2022A recent study presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting found that there was neither a decreased nor increased risk for postpartum depression in patients who received hormonal contraception due to insufficient evidence.
Read More
Combined oral contraceptives for patients with rheumatoid arthritis
February 8th 2022While the use of combined oral contraceptives (COCs) among patients with rheumatoid and autoimmune disorders have focused on safety, a narrative review in the Journal of Obstetrics and Gynaecology Research highlighted the efficacy and benefits of these contraceptives in females with rheumatoid arthritis (RA).
Read More
Efficacy of combined oral contraceptives for treating depression in premenstrual women
February 7th 2022Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).
Read More
Balancing the rewards and risks of hormonal acne treatments
January 31st 2022Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
Read More
Impact of contraceptive coverage policies
January 13th 2022The findings support previous research demonstrating that increased access to emergency contraception does not compromise use of other more effective methods or lead to an increase in reported levels of unprotected sexual intercourse, according to Hawkins.
Read More
Counseling on adverse events of intrauterine contraception
December 2nd 2021Professionals who provide contraception counseling need sufficient training and resources to offer comprehensive information about adverse reactions of intrauterine contraception, according to 2 web-based discussion boards about sexual and reproductive health.
Read More
Increasing access to contraception in the United States
November 11th 2021One year after the close of the Increasing Access to Contraception (IAC) Learning Community, participants had sustained their efforts in support of at least 1 goal: to improve women’s access to the full range of contraceptive options.
Read More
Certain incentives may help those with OUD prevent unintended pregnancy
September 10th 2021Among women with opioid use disorder (OUD) at high risk for unintended pregnancy, on-site contraceptive services coupled with financial incentives to attend follow-up visits to assess contraceptive satisfaction was a significantly more effective and cost-beneficial intervention than without incentives or with usual care, according to a prospective randomized clinical trial in JAMA Psychiatry.
Read More
Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome
August 18th 2021Women with congenital long-QT syndrome (LQTS) have an increased risk of cardiac events, including sudden cardiac death, after the onset of adolescence, perhaps due to the effects of estrogen and progesterone on cardiac potassium channels.
Read More
Study finds risk of pregnancy low prior to IUD placement following recent unprotected sex
August 12th 2021The findings of a secondary analysis from a randomized trial of intrauterine devices (IUDs) for emergency contraception should bolster confidence about the low pregnancy risk when providers insert an IUD following a recent episode of unprotected intercourse.
Read More
Oral contraceptive use during adolescence has small but meaningful link to future depression
July 29th 2021Adolescent oral contraceptive use is associated with a small yet meaningful increased risk of experiencing an episode of major depressive disorder (MDD) in early adulthood, especially among women with no history of MDD in adolescence.
Read More
Contraceptive services, financial incentives may help those with OUD prevent unintended pregnancy
July 26th 2021Among women with opioid use disorder (OUD) at high risk for unintended pregnancy, onsite contraceptive services coupled with financial incentives to attend follow-up visits to assess contraceptive satisfaction was a significantly more efficacious and cost-beneficial intervention than without incentives or with usual care, according to a prospective randomized clinical trial in JAMA Psychiatry.
Read More